• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿CTX-II能否作为膝关节骨关节炎的生物标志物?

Can urinary CTX-II be a biomarker for knee osteoarthritis?

作者信息

Arunrukthavon Piti, Heebthamai Danai, Benchasiriluck Prapasri, Chaluay Supinda, Chotanaphuti Thanainit, Khuangsirikul Saradej

机构信息

Department of Orthopedic Surgery, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

Department of Orthopedic Surgery, Queen Savang Vadhana Memorial Hospital, Sriracha, Chonburi, Thailand.

出版信息

Arthroplasty. 2020 Feb 10;2(1):6. doi: 10.1186/s42836-020-0024-2.

DOI:10.1186/s42836-020-0024-2
PMID:35236476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8796402/
Abstract

BACKGROUND

Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge. Urinary C-terminal cross-linked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers. However, conclusive evidence regarding the use of this biomarker as a tool for early diagnosis is still lacking. The purposes of this study were to compare urinary CTX-II levels in patients with knee OA and in healthy controls, to evaluate the correlation between urinary CTX-II levels, radiographic severity of OA, and patient-reported outcomes and to evaluate the effect of age and gender on urinary CTX-II levels in the Asian populations.

METHODS

Two groups were studied. The OA group included 78 patients with knee OA aged > 40 years who met the diagnostic criteria for knee OA described by the American College of Rheumatology (ACR). The control group consisted of 51 healthy participants age > 40 years without clinical or radiographic evidence of knee OA. Bilateral knee radiographs were taken and classified according to the Kellgren and Lawrence (KL) grading system. Urinary CTX-II was measured using a competitive ELISA test and Western Ontario and Mcmaster Universities Arthritis Index (WOMAC) was also recorded in all participants.

RESULTS

Urinary CTX-II was significantly higher in the OA group than in the control group (p < 0.001). The severe knee OA group (KL grade 3 and 4) had higher urinary CTX-II levels than mild knee OA group (KL grade 2) but the difference did not reach statistical significance (p = 0.2). There was a moderate correlation between urinary CTX-II levels and KL grades (r = 0.405, p < 0.001) and a weak correlation between urinary CTX-II levels and WOMAC index scores (r = 0.367, p < 0.001). Multiple regression analysis showed that urinary CTX-II was independently associated with KL grades. Whereas age, gender, and WOMAC index had no statistically significant influence on the urinary CTX-II levels.

CONCLUSIONS

Patients with knee OA had higher urinary CTX-II levels than healthy controls. Moreover, levels of urinary CTX-II were independently correlated with radiographic severity of knee OA. Age, gender, and patient-reported outcomes exerted no effect on the urinary CTX-II levels.

LEVEL OF EVIDENCE

Diagnostic Level III.

摘要

背景

膝关节骨关节炎(OA)的早期诊断仍然是一项诊断挑战。尿Ⅱ型胶原C端交联肽(尿CTX-II)是潜在的OA生物标志物之一。然而,关于将该生物标志物用作早期诊断工具的确凿证据仍然缺乏。本研究的目的是比较膝关节OA患者和健康对照者的尿CTX-II水平,评估尿CTX-II水平、OA的放射学严重程度和患者报告结局之间的相关性,并评估年龄和性别对亚洲人群尿CTX-II水平的影响。

方法

研究了两组。OA组包括78例年龄>40岁且符合美国风湿病学会(ACR)描述的膝关节OA诊断标准的膝关节OA患者。对照组由51名年龄>40岁、无膝关节OA临床或放射学证据的健康参与者组成。拍摄双侧膝关节X线片,并根据Kellgren和Lawrence(KL)分级系统进行分类。使用竞争性ELISA试验测量尿CTX-II,并记录所有参与者的西安大略和麦克马斯特大学关节炎指数(WOMAC)。

结果

OA组的尿CTX-II显著高于对照组(p<0.001)。重度膝关节OA组(KL 3级和4级)的尿CTX-II水平高于轻度膝关节OA组(KL 2级),但差异无统计学意义(p=0.2)。尿CTX-II水平与KL分级之间存在中度相关性(r=0.405,p<0.001),尿CTX-II水平与WOMAC指数评分之间存在弱相关性(r=0.367,p<0.001)。多元回归分析表明,尿CTX-II与KL分级独立相关。而年龄、性别和WOMAC指数对尿CTX-II水平无统计学显著影响。

结论

膝关节OA患者的尿CTX-II水平高于健康对照者。此外,尿CTX-II水平与膝关节OA的放射学严重程度独立相关。年龄、性别和患者报告结局对尿CTX-II水平无影响。

证据水平

诊断性III级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64a8/8796402/3e98ebeb9ddf/42836_2020_24_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64a8/8796402/f469f72754c2/42836_2020_24_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64a8/8796402/3e98ebeb9ddf/42836_2020_24_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64a8/8796402/f469f72754c2/42836_2020_24_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64a8/8796402/3e98ebeb9ddf/42836_2020_24_Fig2_HTML.jpg

相似文献

1
Can urinary CTX-II be a biomarker for knee osteoarthritis?尿CTX-II能否作为膝关节骨关节炎的生物标志物?
Arthroplasty. 2020 Feb 10;2(1):6. doi: 10.1186/s42836-020-0024-2.
2
C-Terminal Cross-Linked Telopeptides of Type II Collagen as Biomarker for Radiological Knee Osteoarthritis: A Meta-Analysis.Ⅱ型胶原 C 端肽交联作为放射学膝关节骨关节炎的生物标志物:一项荟萃分析。
Cartilage. 2020 Oct;11(4):512-520. doi: 10.1177/1947603518798884. Epub 2018 Sep 15.
3
Correlation Analysis of C-terminal telopeptide of collagen type II and Interleukin-1β for Early Diagnosis of Knee Osteoarthritis.Ⅱ型胶原 C 末端肽与白介素-1β在膝骨关节炎早期诊断中的相关性分析。
Orthop Surg. 2020 Feb;12(1):286-294. doi: 10.1111/os.12586. Epub 2019 Dec 16.
4
Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis.骨和软骨转换生物标志物与性别、疼痛类别和膝关节骨关节炎放射学严重程度的相关性。
Arthritis Res Ther. 2019 Sep 3;21(1):203. doi: 10.1186/s13075-019-1987-7.
5
Increased Urinary Concentration of C-Terminal Telopeptide of Type II Collagen and Pain by Radiographic Grade in Women with Knee Osteoarthritis in Northeastern Mexico: A Cross-Sectional Study.墨西哥东北部膝骨关节炎女性中,尿Ⅱ型胶原C端肽浓度与影像学分级所致疼痛增加的横断面研究
Biores Open Access. 2020 Feb 12;9(1):7-12. doi: 10.1089/biores.2019.0003. eCollection 2020.
6
Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.膝关节骨关节炎患者骨、软骨和滑膜组织代谢生化标志物的横断面评估:与疾病活动度和关节损伤的关系
Ann Rheum Dis. 2001 Jun;60(6):619-26. doi: 10.1136/ard.60.6.619.
7
Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.生化标志物可识别骨关节炎中骨和软骨降解的影响因素——性别、Kellgren-Lawrence (KL) 评分、体重指数 (BMI)、口服鲑鱼降钙素 (sCT) 治疗和昼夜变化的影响。
BMC Musculoskelet Disord. 2010 Jun 17;11:125. doi: 10.1186/1471-2474-11-125.
8
CTX-II and YKL-40 in early diagnosis and treatment evaluation of osteoarthritis.CTX-II和YKL-40在骨关节炎早期诊断及治疗评估中的应用
Exp Ther Med. 2019 Jan;17(1):423-431. doi: 10.3892/etm.2018.6960. Epub 2018 Nov 12.
9
Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men.尿CTX-II和葡萄糖基-半乳糖基吡啶啉与男性膝关节影像学骨关节炎的存在及严重程度相关。
Ann Rheum Dis. 2006 Jul;65(7):871-7. doi: 10.1136/ard.2005.042895. Epub 2005 Nov 10.
10
Transforming Growth Factor Beta1 being considered a novel biomarker in knee osteoarthritis.转化生长因子β 1 被认为是膝骨关节炎的一种新型生物标志物。
Clin Chim Acta. 2017 Sep;472:96-101. doi: 10.1016/j.cca.2017.07.021. Epub 2017 Jul 21.

引用本文的文献

1
Estimation of Serum C-terminal Cross-linked Telopeptide Type II Collagen (CTX II) Level to Diagnose Early Knee Osteoarthritis.血清II型胶原C末端交联肽(CTX II)水平评估对早期膝关节骨关节炎的诊断价值
Malays Orthop J. 2025 Jul;19(2):18-24. doi: 10.5704/MOJ.2507.003.
2
Identification of Surrogate Biomarkers for Mucopolysaccharidosis Type IVA.IVA型黏多糖贮积症替代生物标志物的鉴定
Int J Mol Sci. 2025 May 21;26(10):4940. doi: 10.3390/ijms26104940.
3
Increased Degenerative Biomarkers in Females with Patellofemoral Pain: A Cross-Sectional Analysis with 6-Month Progression.

本文引用的文献

1
Cartilage oligomeric matrix protein, C-terminal cross-linking telopeptide of type II collagen, and matrix metalloproteinase-3 as biomarkers for knee and hip osteoarthritis (OA) diagnosis: a systematic review and meta-analysis.软骨寡聚基质蛋白、Ⅱ型胶原 C 端交联肽和基质金属蛋白酶-3 作为膝关节和髋关节骨关节炎 (OA) 诊断的生物标志物:系统评价和荟萃分析。
Osteoarthritis Cartilage. 2019 May;27(5):726-736. doi: 10.1016/j.joca.2018.10.009. Epub 2018 Nov 2.
2
C-Terminal Cross-Linked Telopeptides of Type II Collagen as Biomarker for Radiological Knee Osteoarthritis: A Meta-Analysis.Ⅱ型胶原 C 端肽交联作为放射学膝关节骨关节炎的生物标志物:一项荟萃分析。
Cartilage. 2020 Oct;11(4):512-520. doi: 10.1177/1947603518798884. Epub 2018 Sep 15.
3
髌股关节疼痛女性中退化生物标志物增加:一项为期6个月进展情况的横断面分析
Diseases. 2025 May 17;13(5):155. doi: 10.3390/diseases13050155.
4
Gold Nanoparticles as a Tool to Detect Biomarkers in Osteoarthritis: New Insights.金纳米颗粒作为检测骨关节炎生物标志物的工具:新见解
Indian J Microbiol. 2025 Mar;65(1):253-276. doi: 10.1007/s12088-024-01331-5. Epub 2024 Jun 20.
5
Construction of multi-scale feature fusion segmentation model of MRI knee images based on dual attention mechanism weighted aggregation.基于双注意力机制加权聚合的 MRI 膝关节图像多尺度特征融合分割模型的构建。
Technol Health Care. 2024;32(S1):277-286. doi: 10.3233/THC-248024.
6
Soluble and EV-Associated Diagnostic and Prognostic Biomarkers in Knee Osteoarthritis Pathology and Detection.膝关节骨关节炎病理与检测中可溶性及细胞外囊泡相关的诊断和预后生物标志物
Life (Basel). 2023 Jan 27;13(2):342. doi: 10.3390/life13020342.
7
Molecular Assessment of Healthy Pathological Articular Cartilages in Physically Active People: A Scoping Review.生理性活跃人群健康关节软骨的分子评估:范围综述。
Int J Mol Sci. 2023 Feb 11;24(4):3662. doi: 10.3390/ijms24043662.
8
Effects of Greenshell™ mussel intervention on biomarkers of cartilage metabolism, inflammatory markers and joint symptoms in overweight/obese postmenopausal women: A randomized, double-blind, and placebo-controlled trial.绿壳贻贝干预对超重/肥胖绝经后女性软骨代谢生物标志物、炎症标志物及关节症状的影响:一项随机、双盲、安慰剂对照试验。
Front Med (Lausanne). 2022 Dec 5;9:1063336. doi: 10.3389/fmed.2022.1063336. eCollection 2022.
9
Efficacy of sCOMP and sCTX-I in Diagnosis of Knee Osteoarthritis.sCOMP和sCTX-I在膝关节骨关节炎诊断中的效能
Indian J Orthop. 2022 Jul 3;56(9):1565-1571. doi: 10.1007/s43465-022-00686-5. eCollection 2022 Sep.
10
Associations between serum biomarkers of cartilage metabolism and serum hyaluronic acid, with risk factors, pain categories, and disease severity in knee osteoarthritis: a pilot study.关节软骨代谢的血清生物标志物与血清透明质酸、膝关节骨关节炎的危险因素、疼痛类别和疾病严重程度的相关性:一项初步研究。
BMC Musculoskelet Disord. 2022 Mar 2;23(1):195. doi: 10.1186/s12891-022-05133-y.
Meta-analysis of urinary C-terminal telopeptide of type II collagen as a biomarker in osteoarthritis diagnosis.尿II型胶原C末端肽作为骨关节炎诊断生物标志物的荟萃分析。
J Orthop Translat. 2017 Aug 15;13:50-57. doi: 10.1016/j.jot.2017.06.005. eCollection 2018 Apr.
4
Epidemiology of osteoarthritis: literature update.骨关节炎的流行病学:文献更新。
Curr Opin Rheumatol. 2018 Mar;30(2):160-167. doi: 10.1097/BOR.0000000000000479.
5
Comparative study of CTX-II, Zn2+, and Ca2+ from the urine for knee osteoarthritis patients and healthy individuals.膝关节骨关节炎患者与健康个体尿液中CTX-II、Zn2+和Ca2+的对比研究。
Medicine (Baltimore). 2017 Aug;96(32):e7593. doi: 10.1097/MD.0000000000007593.
6
Early osteoarthritis of the knee.膝关节早期骨关节炎
Knee Surg Sports Traumatol Arthrosc. 2016 Jun;24(6):1753-62. doi: 10.1007/s00167-016-4068-3. Epub 2016 Mar 21.
7
The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK.全身生化标志物反映早期膝关节和髋关节影像学骨关节炎的存在、发病率及进展的能力:来自CHECK研究的数据
Osteoarthritis Cartilage. 2015 Aug;23(8):1388-97. doi: 10.1016/j.joca.2015.03.023. Epub 2015 Mar 26.
8
Relationship between CTX-II and patient characteristics, patient-reported outcome, muscle strength, and rehabilitation in patients with a focal cartilage lesion of the knee: a prospective exploratory cohort study of 48 patients.CTX-II与膝关节局灶性软骨损伤患者的特征、患者报告的结局、肌肉力量及康复之间的关系:一项对48例患者的前瞻性探索性队列研究
BMC Musculoskelet Disord. 2014 Mar 24;15:99. doi: 10.1186/1471-2474-15-99.
9
Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis.尿C端肽、血清软骨寡聚蛋白和基质金属蛋白酶降解的II型胶原蛋白的大规模荟萃分析及其在骨关节炎患病率、发病率和进展中的作用。
Osteoarthritis Cartilage. 2014 May;22(5):683-9. doi: 10.1016/j.joca.2014.02.007. Epub 2014 Feb 25.
10
Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis : the Matsudai knee osteoarthritis survey.尿CTX-II和NTX-I在评估膝关节放射学骨关节炎中的应用:松代膝关节骨关节炎调查
J Orthop Sci. 2014 May;19(3):429-36. doi: 10.1007/s00776-014-0535-1. Epub 2014 Feb 7.